Sleep Number price target raised to $13.50 from $12 at Wedbush

Wedbush raised the firm’s price target on Sleep Number to $13.50 from $12 and keeps a Neutral rating on the shares. Sleep Number’s Q4 results were better than expected on the top and bottom lines, and while the outlook for sales and EBTIDA were below consensus estimates, the margin outlook remains encouraging and Sleep Number’s improving demand trajectory in Q4 and February could drive further upside if momentum continues, the analyst tells investors in a research note.